Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

IBD medications during pregnancy and lactation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Too many people with viral hepatitis are diagnosed late - with dire consequences

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Many European countries 'flying blind' in their efforts to eliminate viral hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. NAFLD: Cardiovascular complications of NAFLD-they do matter

    Publikation: Bidrag til tidsskriftLetterpeer review

  4. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Personalized B cell response to the Lactobacillus rhamnosus GG probiotic in healthy human subjects: a randomized trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mucosal vitamin D signaling in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Telomere dysfunction activates YAP1 to drive tissue inflammation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
IBD often affects patients during their peak reproductive years. Several drugs are available for the treatment of IBD and new drugs are continuously in the pipeline. As long-term administration of medications is often necessary, the safety of drug therapy during pregnancy and breast-feeding needs to be considered in daily clinical practice. The aim of this Review is to summarize the latest information concerning the safety of medications used to treat IBD during pregnancy and lactation, as well as their effect on fertility. Although only thalidomide and methotrexate are absolutely contraindicated during pregnancy and breast-feeding, alternatives to ciprofloxacin, natalizumab and sodium phosphate should also be considered for pregnant women. Breast-feeding is also discouraged while on treatment with ciclosporin, metronidazole and ciprofloxacin. However, therapy with 5-aminosalicylic acid preparations, glucocorticoids, thiopurines and TNF inhibitors are acceptable during pregnancy and lactation. Pregnant women who have symptomatic IBD or who require therapy should have the opportunity to discuss any associated risks to their pregnancy and infant with the appropriate consultants. By ensuring that the patient and her family are informed, the clinical outcome might be optimized.
OriginalsprogEngelsk
TidsskriftNature Reviews. Gastroenterology & Hepatology
Vol/bind11
Udgave nummer2
Sider (fra-til)116-127
Antal sider12
ISSN1759-5045
DOI
StatusUdgivet - 2014

ID: 38907531